Floatz logo

PREFEST COMPONENT NORGESTIMATE

Ovary Cyst

Benha UniversitySmall moleculePhase 2/3Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Ovary Cyst cohort.

Asset / SponsorPhaseRating
ORSYTHIA COMPONENT ETHINYL ESTRADIOL
Benha University
Phase 2/3B
Dydrogesterone
Zagazig University
N/AD

Same molecule, other indications

PREFEST COMPONENT NORGESTIMATE is also rated in:

migraine disorderDormant
CC
Indicative ·
47 / 100
View asset →
Depressive Disorder, MajorDormant
CC
Indicative ·
44 / 100
View asset →
cystic fibrosisDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →